Cargando…
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
Recessive dystrophic epidermolysis bullosa is a rare and severe genetic skin disease resulting in blistering of the skin and mucosa. Recessive dystrophic epidermolysis bullosa (RDEB) is caused by a wide variety of mutations in COL7A1-encoding type VII collagen, which is essential for dermal-epiderma...
Autores principales: | Izmiryan, Araksya, Ganier, Clarisse, Bovolenta, Matteo, Schmitt, Alain, Mavilio, Fulvio, Hovnanian, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077132/ https://www.ncbi.nlm.nih.gov/pubmed/30195791 http://dx.doi.org/10.1016/j.omtn.2018.06.008 |
Ejemplares similares
-
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017) -
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa
por: Webber, Beau R, et al.
Publicado: (2016) -
Novel biallelic variants in COL7A1 cause recessive dystrophic epidermolysis bullosa
por: Yang, Neng, et al.
Publicado: (2020) -
CRISPR/Cas9-Mediated Generation of COL7A1-Deficient
Keratinocyte Model of Recessive Dystrophic
Epidermolysis Bullosa
por: Alipour, Farzad, et al.
Publicado: (2023) -
Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
por: Bonafont, Jose, et al.
Publicado: (2021)